技術指標
指標
數值
方向
MACD(12,26,9)
-0.040
賣出
RSI(14)
25.136
賣出
STOCH(KDJ)(9,3,3)
14.929
超賣
ATR(14)
0.103
低波動
CCI(14)
-107.674
賣出
Williams %R
88.479
超賣
TRIX(12,20)
-1.616
賣出
StochRSI(14)
0.000
超賣
搜尋
BioNexus Gene Lab Corp
BGLC添加自選
1.280USD
-0.040-3.03%
收盤 07-31 16:00（美東）報價延遲15分鐘
3.09M總市值
虧損本益比TTM
關鍵數據
--今開
1.370最高
10.01K成交量
虧損本益比TTM
--本益比動
--股利TTM
0.41%換手率
1.320昨收
1.270最低
10.76K成交額
虧損本益比靜
0.38市淨率
0.00%股息率 TTM
-31.37%ROA
15.60052週最高
0.43量比
-1.60M淨利潤
2.42M總股本
-1.4855每股盈餘TTM
2.20Beta
-36.62%ROE
1.92052週最低
7.58%振幅
-3.46%毛利率
3.09M總市值
-7.79回報/風險
4.49%風險率
TradingKey BioNexus Gene Lab Corp股票評分
單位: USD 更新時間: 2026-07-31操作建議
BioNexus Gene Lab Corp當前公司基本面數據相對非常健康，增長潛力較大。當前估值合理，在生物技術與醫療研究行業排名190/385位。機構持股佔比非常高，中期看，股價處於下降通道。近一個月，市場表現非常差，但基本面評分較高。目前股價在壓力位和支撐位之間，可以做區間波段操作。
BioNexus Gene Lab Corp評分
壓力支撐
由於公司未披露，未能獲取相關數據
多維評測
本期評分
上期評分
公司輿情
過去24小時
熱度
過冷
過熱
看好
BioNexus Gene Lab Corp亮點
亮點風險
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
業績增長期
公司處於發展階段，最新年度總收入7.42M美元
估值高估
公司最新PE估值-0.89，處於3年歷史高位
機構加倉
最新機構持股50.43K股，環比增加16.55%
分析師目標
基於
0
分析師
--
評級
--
目標均價
--
漲幅空間
BioNexus Gene Lab Corp新聞
即將為您帶來更多新聞，敬請期待。 。 。
技術指標
移動平均線
指標
數值
方向
MA5
1.344
賣出
MA10
1.461
賣出
MA20
1.623
賣出
MA50
1.976
賣出
MA100
2.099
賣出
MA200
2.971
賣出
財務指標
每股收益
由於公司未披露，未能獲取相關數據
營業總收入
由於公司未披露，未能獲取相關數據
BioNexus Gene Lab Corp簡介
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
公司代碼BGLC
公司BioNexus Gene Lab Corp
CEOTan (Lee Su-Leng)
網址https://www.bionexusgenelab.com/
公司股東
相關品種
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%熱門品種
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
常見問題
BioNexus Gene Lab Corp(BGLC)的當前股價是多少？
BioNexus Gene Lab Corp(BGLC)的當前股價是 1.28。
BioNexus Gene Lab Corp 的股票代碼是什麼？
BioNexus Gene Lab Corp的股票代碼是BGLC。
BioNexus Gene Lab Corp股票的52週最高點是多少？
BioNexus Gene Lab Corp股票的52週最高點是15.60。
BioNexus Gene Lab Corp股票的52週最低點是多少？
BioNexus Gene Lab Corp股票的52週最低點是1.92。
BioNexus Gene Lab Corp的市值是多少？
BioNexus Gene Lab Corp的市值是3.09M。
BioNexus Gene Lab Corp(BGLC)股票的每股收益（EPS TTM）是多少
BioNexus Gene Lab Corp(BGLC)股票的每股收益（EPS TTM）是-1.61。